Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes

Journal of Autoimmunity

Volumn 33, Issue 2, 2009, Pages 155-164

  Lempainen, Johanna ^a,b   Vaarala, Outi ^c   Mäkelä, Miia ^a   Veijola, Riitta ^d   Simell, Olli ^a   Knip, Mikael ^e,f   Hermann, Robert ^a,g   Ilonen, Jorma ^a,h  

^a UNIVERSITY OF TURKU   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Autoantibody appearance; Cow's milk formula exposure; Interaction; PTPN22; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; INSULIN ANTIBODY; ISLET ANTIGEN 2 ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ARTIFICIAL MILK; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; ANIMALS; ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNITY; CASE-CONTROL STUDIES; CATTLE; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT FORMULA; MALE; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; REGRESSION ANALYSIS;

EID: 68249089241     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.04.003     Document Type: Article

References (52)

1. Vyse T.J., and Todd J.A. Genetic analysis of autoimmune disease. Cell 85 (1996) 311-318
2. Jahromi M.M., and Eisenbarth G.S. Genetic determinants of type 1 diabetes across populations. Ann N Y Acad Sci 1079 (2006) 289-299
3. Maier L.M., and Wicker L.S. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17 (2005) 601-608
4. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 (2004) 337-338
5. Hermann R., Lipponen K., Kiviniemi M., Kakko T., Veijola R., Simell O., et al. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49 (2006) 1198-1208
6. Hummel M., Bonifacio E., Schmid S., Walter M., Knopff A., and Ziegler A.G. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140 (2004) 882-886
7. Zhang L., Nakayama M., and Eisenbarth G.S. Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 20 (2008) 111-118
8. Paronen J., Knip M., Savilahti E., Virtanen S.M., Ilonen J., Åkerblom H.K., et al. Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes 49 (2000) 1657-1665
9. Tiittanen M., Paronen J., Savilahti E., Virtanen S.M., Ilonen J., Knip M., et al. Dietary insulin as an immunogen and tolerogen. Pediatr Allergy Immunol 17 (2006) 538-543
10. Vaarala O., Knip M., Paronen J., Hämäläinen A.M., Muona P., Väätäinen M., et al. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 48 (1999) 1389-1394
11. Koczwara K., Muller D., Achenbach P., Ziegler A.G., and Bonifacio E. Identification of insulin autoantibodies of IgA isotype that preferentially target non-human insulin. Clin Immunol 124 (2007) 77-82
12. Åkerblom H.K., Virtanen S.M., Ilonen J., Savilahti E., Vaarala O., Reunanen A., et al. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia 48 (2005) 829-837
13. Holmberg H., Wahlberg J., Vaarala O., and Ludvigsson J. Short duration of breast-feeding as a risk-factor for beta-cell autoantibodies in 5-year-old children from the general population. Br J Nutr 97 (2007) 111-116
14. Kimpimäki T., Erkkola M., Korhonen S., Kupila A., Virtanen S.M., Ilonen J., et al. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity. Diabetologia 44 (2001) 63-69
15. Rosenbauer J., Herzig P., and Giani G. Early infant feeding and risk of type 1 diabetes mellitus-a nationwide population-based case-control study in pre-school children. Diabetes Metab Res Rev 24 (2008) 211-222
16. Virtanen S.M., Kenward M.G., Erkkola M., Kautiainen S., Krönberg-Kippilä C., Hakulinen T., et al. Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49 (2006) 1512-1521
17. Ziegler A.G., Schmid S., Huber D., Hummel M., and Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. Jama 290 (2003) 1721-1728
18. Pérez-Bravo F., Carrasco E., Gutierrez-Lopez M.D., Martinez M.T., Lopez G., and GarciadelosRios M. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J Mol Med 74 (1996) 105-109
19. Kostraba J.N., Cruickshanks K.J., Lawlerheavner J., Jobim L.F., Rewers M.J., Gay E.C., et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 42 (1993) 288-295
20. Virtanen S.M., Läärä E., Hyppönen E., Reijonen H., Räsänen L., Aro A., et al. Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes 49 (2000) 912-917
21. Laine A.P., Holmberg H., Nilsson A., Ortqvist E., Kiviniemi M., Vaarala O., et al. Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populations. Dis Markers 23 (2007) 139-145
22. Doroudis, K., Laine, A.P., Heinonen, M., Hermann, R., Lipponen, K., Veijola, R., Simell, O., Knip, M., Uibo, R., Ilonen, J., Kisand, K. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease Rates. Hum Immunol, in press.
23. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A.M., et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44 (2001) 290-297
24. Näntö-Salonen K., Kupila A., Simell S., Siljander H., Salonsaari T., Hekkala A., et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372 (2008) 1746-1755
25. Kimpimäki T., Kulmala P., Savola K., Kupila A., Korhonen S., Simell T., et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87 (2002) 4572-4579
26. Sjöroos M., Iitia A., Ilonen J., Reijonen H., and Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18 (1995) 870-877
27. Laaksonen M., Pastinen T., Sjöroos M., Kuokkanen S., Ruutiainen J., Sumelahti M.L., et al. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol 122 (2002) 140-145
28. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., and Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34 (2004) 543-548
29. Kiviniemi M., Nurmi J., Turpeinen H., Lövgren T., and Ilonen J. A homogeneous high-throughput genotyping method based on competitive hybridization. Clin Biochem 36 (2003) 633-640
30. Eurodiab Ace Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355 (2000) 873-876
31. Knip M., and Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7 (2008) 550-557
32. Onkamo P., Väänänen S., Karvonen M., and Tuomilehto J. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42 (1999) 1395-1403
33. Gillespie K.M., Bain S.C., Barnett A.H., Bingley P.J., Christie M.R., Gill G.V., et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364 (2004) 1699-1700
34. Hermann R., Knip M., Veijola R., Simell O., Laine A.P., Åkerblom H.K., et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure?. Diabetologia 46 (2003) 420-425
35. Redondo M.J., Yu L., Hawa M., Mackenzie T., Pyke D.A., Eisenbarth G.S., et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44 (2001) 354-362
36. Knip M. Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes. Rev Endocr Metab Disord 4 (2003) 213-223
37. Norris J.M., Beaty B., Klingensmith G., Yu L., Hoffman M., Chase H.P., et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). Jama 276 (1996) 609-614
38. Virtanen S.M., and Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 78 (2003) 1053-1067
39. Hermann R., Laine A.P., Veijola R., Vahlberg T., Simell S., Lähde J., et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 48 (2005) 1766-1775
40. Vaarala O., Paronen J., Otonkoski T., and Åkerblom H.K. Cow milk feeding induces antibodies to insulin in children-a link between cow milk and insulin-dependent diabetes mellitus?. Scand J Immunol 47 (1998) 131-135
41. Aarnisalo J., Treszl A., Svec P., Marttila J., Öling V., Simell O., et al. Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun (2008)
42. Rieck M., Arechiga A., Onengut-Gumuscu S., Greenbaum C., Concannon P., and Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 179 (2007) 4704-4710
43. Vang T., Congia M., Macis M.D., Musumeci L., Orru V., Zavattari P., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37 (2005) 1317-1319
44. Vang T., Miletic A.V., Arimura Y., Tautz L., Rickert R.C., and Mustelin T. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol (2007)
45. Kennedy G.C., German M.S., and Rutter W.J. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 9 (1995) 293-298
46. Pugliese A., Zeller M., Fernandez Jr. A., Zalcberg L.J., Bartlett R.J., Ricordi C., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15 (1997) 293-297
47. Vafiadis P., Ounissi-Benkalha H., Palumbo M., Grabs R., Rousseau M., Goodyer C.G., et al. Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab 86 (2001) 3705-3710
48. Bennett S.T., Lucassen A.M., Gough S.C., Powell E.E., Undlien D.E., Pritchard L.E., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9 (1995) 284-292
49. Bennett S.T., Wilson A.J., Cucca F., Nerup J., Pociot F., McKinney P.A., et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 9 (1996) 415-421
50. Vafiadis P., Bennett S.T., Colle E., Grabs R., Goodyer C.G., and Polychronakos C. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. J Autoimmun 9 (1996) 397-403
51. Chentoufi A.A., and Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51 (2002) 1383-1390
52. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15 (1997) 289-292